Literature DB >> 26586007

Atypical clinical and radiological course of a patient with Canavan disease.

Catherine Sarret1,2, Odile Boespflug-Tanguy3,4, Diana Rodriguez4,5,6.   

Abstract

Canavan disease (CD) is a rare metabolic disorder caused by aspartoacylase (ASPA) deficiency. It leads to severe neurological degeneration with spongiform brain degeneration. Accumulation of N-acetylaspartate (NAA) in brain and urine is specific to the disease and guides diagnosis. Magnetic resonance imaging (MRI) usually shows diffuse white matter abnormalities with involvement of the basal ganglia. Mild forms of the disease with a more favorable clinical course and radiological involvement of the basal ganglia without white matter abnormalities have also been reported. Here we report an atypical case of a girl aged nine years with CD. The disease started at the classical age of five months. Classical elevation of NAA in brain and urine was present and genetic analysis identified mutations in the ASPA gene. However, clinical evolution was milder than typical CD, with partial motor impairment and relatively well-preserved cognitive skills. MRI was also atypical with low white matter involvement and unusual topography and evolution of abnormalities in the basal ganglia.

Entities:  

Keywords:  1H magnetic resonance spectroscopy; Aspartoacylase; Canavan disease; Magnetic resonance imaging; N-acetyl-aspartate

Mesh:

Substances:

Year:  2015        PMID: 26586007     DOI: 10.1007/s11011-015-9767-9

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  16 in total

1.  The spectrum of mutations of the aspartoacylase gene in Canavan disease in non-Jewish patients.

Authors:  O N Elpeleg; A Shaag
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

2.  Homozygosity for mutation G212A of the gene for aspartoacylase is associated with atypical form of Canavan's disease.

Authors:  M Velinov; N Zellers; J Styles; K Wisniewski
Journal:  Clin Genet       Date:  2007-12-06       Impact factor: 4.438

3.  Atypical MRI findings in Canavan disease: a patient with a mild course.

Authors:  C Yalcinkaya; G Benbir; G S Salomons; E Karaarslan; M O Rolland; C Jakobs; M S van der Knaap
Journal:  Neuropediatrics       Date:  2005-10       Impact factor: 1.947

4.  Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease.

Authors:  Chikkathur N Madhavarao; Peethambaran Arun; John R Moffett; Sylvia Szucs; Sankar Surendran; Reuben Matalon; James Garbern; Diana Hristova; Anne Johnson; Wei Jiang; M A Aryan Namboodiri
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-22       Impact factor: 11.205

5.  Ablating N-acetylaspartate prevents leukodystrophy in a Canavan disease model.

Authors:  Fuzheng Guo; Peter Bannerman; Emily Mills Ko; Laird Miers; Jie Xu; Travis Burns; Shuo Li; Ernest Freeman; Jennifer A McDonough; David Pleasure
Journal:  Ann Neurol       Date:  2015-03-27       Impact factor: 10.422

6.  Canavan disease, a rare early-onset human spongiform leukodystrophy: insights into its genesis and possible clinical interventions.

Authors:  M H Baslow; D N Guilfoyle
Journal:  Biochimie       Date:  2012-11-11       Impact factor: 4.079

7.  Magnetic resonance imaging in juvenile Canavan disease.

Authors:  P B Toft; R Geiss-Holtorff; M O Rolland; O Pryds; W Müller-Forell; E Christensen; W Lehnert; H C Lou; D Ott; J Hennig
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

8.  Canavan disease - unusual imaging features in a child with mild clinical presentation.

Authors:  Ho V Nguyen; Gisele E Ishak
Journal:  Pediatr Radiol       Date:  2014-08-09

Review 9.  Canavan disease: clinical features and recent advances in research.

Authors:  Hideki Hoshino; Masaya Kubota
Journal:  Pediatr Int       Date:  2014-08       Impact factor: 1.524

Review 10.  Axon-glial signaling and the glial support of axon function.

Authors:  Klaus-Armin Nave; Bruce D Trapp
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

View more
  3 in total

1.  Investigation of the motor system in two siblings with Canavan's disease: a combined transcranial magnetic stimulation (TMS) - diffusion tensor imaging (DTI) study.

Authors:  V K Kimiskidis; Vasileios Papaliagkas; S Papagiannopoulos; D Zafeiriou; D Kazis; E Tsatsali-Foroglou; Z Kouvatsou; V Kapina; D Koutsonikolas; G Anogianakis; T Geroukis; S Bostantjopoulou
Journal:  Metab Brain Dis       Date:  2017-01-28       Impact factor: 3.584

Review 2.  Cytotoxic edema and diffusion restriction as an early pathoradiologic marker in canavan disease: case report and review of the literature.

Authors:  Steven T Merrill; Gary R Nelson; Nicola Longo; Joshua L Bonkowsky
Journal:  Orphanet J Rare Dis       Date:  2016-12-07       Impact factor: 4.123

3.  Clinically Distinct Phenotypes of Canavan Disease Correlate with Residual Aspartoacylase Enzyme Activity.

Authors:  Marisa I Mendes; Desirée Ec Smith; Ana Pop; Pascal Lennertz; Matilde R Fernandez Ojeda; Warsha A Kanhai; Silvy Jm van Dooren; Yair Anikster; Ivo Barić; Caroline Boelen; Jaime Campistol; Lonneke de Boer; Ariana Kariminejad; Hulya Kayserili; Agathe Roubertie; Krijn T Verbruggen; Christine Vianey-Saban; Monique Williams; Gajja S Salomons
Journal:  Hum Mutat       Date:  2017-02-14       Impact factor: 4.878

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.